Sun Pharmaceutical Industries Limited — Updates, 11-06-2026: General Updates

Sun Pharma has announced its 34th Annual General Meeting. A final dividend of ₹5 per equity share for FY25-26 is proposed, subject to approval. Shareholders' eligibility for the dividend will be determined, with payment to follow. TDS applies, requiring document submission by the eligibility cutoff.